Sugammadex on Remifentanil Ce for Preventing Emergence Cough in Male

• Status: Completed
• Trial end date: 2018-12-31
• Target enrollment: 0
• Participant gender: Male

Summary

The primary purpose of this study is to investigate the optimal Ce of remifentanil for preventing emergence cough following extubation during general anesthesia in male patients who are reversed with sugammadex or neostigmine.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ajou University School of Medicine
• Treatments: Glycopyrrolate; Neostigmine

Criteria

Inclusion Criteria:

• Laparoscopic cholecystectomy under general anesthesia

Exclusion Criteria:

• BMI > 30 kg/m2, respiratory infection, uncontrolled hypertension